Showing results (41-50 of 58) with videos related to
Sort By:
Pageof 6
The Journal of Surgical Research|July 31, 2003
In vitro induction of tumor-specific HLA class I-restricted CD8+ cytotoxic T lymphocytes from patients with locally advanced breast cancer by tumor antigen-pulsed autologous dendritic cellsRena Kass, Jamshed Agha, Stefania Bellone, et al.Cancer|January 2, 2009
Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancerStefania Bellone, Simone Anfossi, Timothy J O'Brien, et al.Gynecologic Oncology|October 7, 2014
Galectin-3 inhibition suppresses drug resistance, motility, invasion and angiogenic potential in ovarian cancerLeonardo Mirandola, Yuefei Yu, Martin J Cannon, et al.American Journal of Obstetrics and Gynecology|November 4, 2008
Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancerStefania Bellone, Simone Anfossi, Timothy J O'Brien, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 10, 2011
Cancer testis antigen, ropporin, is a potential target for multiple myeloma immunotherapyMaurizio Chiriva-Internati, Leonardo Mirandola, Yuefei Yu, et al.Cancer Research|October 11, 2017
IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian CancerPurushottam Lamichhane, Lavakumar Karyampudi, Barath Shreeder, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Overexpression of HER-2/neu in uterine serous papillary cancerAlessandro D Santin, Stefania Bellone, Murat Gokden, et al.International Journal of Cancer|August 12, 2004
Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapyAlessandro D Santin, Fenghuang Zhan, Stefania Bellone, et al.Journal for Immunotherapy of Cancer|November 2, 2023
Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockadeYan Luo, Barath Shreeder, James W Jenkins, et al.Virology|January 5, 2005
Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapyAlessandro D Santin, Fenghuang Zhan, Eliana Bignotti, et al.Pageof 6